CME Presentations




  • Sheldon Fields, PhD, RN, FNP-BC, AACRN, FAANP, FNAP, FAAN

    Sheldon Fields, PhD, RN, FNP-BC, AACRN, FAANP, FNAP, FAAN

    Sheldon Fields, PhD, RN, FNP-BC, AACRN, FAANP, FNAP, FAAN

    Associate Dean for Equity and Inclusion

    Dr. Sheldon Fields is an HIV-prevention research scientist who has maintained a primary focus on HIV prevention and treatment among underserved populations. He completed his PhD in nursing science from Pennsylvania State University and his post-doctoral work in the Center for AIDS Prevention Studies at the University of California, San Francisco. A lifetime member of the National Black Nurses Association, he currently serves as its first vice president. In 2020, Dr. Fields was appointed as the inaugural associate dean for equity and inclusion in the Ross and Carol Nese College of Nursing and received the Towers Pinnacle Award from the American Association of Nurse Practitioners (AANP). He holds fellowship status in AANP, the National Academies of Practice, and the American Academy of Nursing.
  • Onyema Ogbuagu, MD, FACP, FIDSA

    Onyema Ogbuagu, MD, FACP, FIDSA

    Onyema Ogbuagu, MD, FACP, FIDSA

    Associate Professor of Medicine

    Onyema Ogbuagu, MBBCh, FACP, FIDSA is an associate professor of medicine in the clinician-educator track and director of the HIV Clinical Trials program within the Yale AIDS Program in the Section of Infectious Diseases at Yale School of Medicine. Dr. Ogbuagu’s clinical responsibilities include educating and training medical students, residents, and infectious-diseases fellows in inpatient and outpatient settings. He also continues to mentor medical residents and junior faculty in Rwanda in quality improvement and clinical research projects that are locally relevant and address important infectious-disease problems, particularly the HIV/AIDS epidemic and antimicrobial resistance.
  • Mamta Jain,  MD, MPH, FIDSA

    Mamta Jain, MD, MPH, FIDSA

    Mamta Jain, MD, MPH, FIDSA

    Professor Infectious Diseases

    Mamta K. Jain, MD, MPH, FIDSA is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in infectious diseases and conducts clinical trials to evaluate new therapies for HIV, hepatitis C, influenza, and now COVID-19. Her research focuses on improving clinical outcomes for those with HIV and viral hepatitis, and she has received significant grant support for her work. Dr. Jain is a fellow of the Infectious Diseases Society of America and is on the Board of Directors for the HIV Medicine Association.

CME Information

Global Logo Global LogoPQH Logo

Promising Therapeutic Approaches and Cultural Sensitivity to Tackle the Unmet Needs of Heavily Treatment-Experienced People Living with HIV

Jointly provided by Association of Aids Care (ANAC) Partners for Advancing Clinical Education (PACE), and PlatformQ Health Education, LLC.


This program has been supported by an independent educational grant from Gilead Sciences, Inc.


Wednesday, August 30, 2023 from 4:00-5:00pm ET


The educational design of this activity addresses the needs of infectious disease specialists, PCPs, NPs/PAs, nurses, pharmacists, case managers, patient navigators, and other HCPs involved in the care of patients living with HIV.


Heavily treatment‐experienced (HTE) people living with HIV (PLWH) have limited antiretroviral (ARV) options to support the achievement of treatment goals and are often unable to achieve virologic suppression. The challenge of treatment failure in HTE PLWH is multifaceted and requires clinicians to be familiar with factors that influence inadequate virologic suppression, including biological, cultural, and socioeconomic issues, so they can anticipate when patients are at higher risk of treatment failure.

Join an expert panel for an in-depth discussion of the guideline‐directed management of HTE PLWH, emerging agents that could improve virologic suppression, and culturally competent care for patients in BIPOC (Black, indigenous, or people of color) communities. Panelists will review the guidelines for formulating new and effective ARV regimens, along with long‐acting and novel agents that could improve HTE patient outcomes. Strategies will also be shared to deliver HIV care in a culturally appropriate manner that fosters respect, comfort, and engagement among patients.

Do you have patients with HIV from BIPOC communities who would benefit from education on treatment options and available support resources? Direct your patients to to access the companion activity, “Elevating the Voice of Treatment‐Experienced Patients Living with HIV: Treatment Options and Self‐Advocacy in Patients from BIPOC Communities.”


After completing this activity, the participant should be better able to:
  • Describe the relationship between unique social determinants of health and suboptimal virologic suppression in heavily treatment‐experienced (HTE) patients from BIPOC communities
  • Discuss approaches to ARV management of the HTE patient after treatment failure
  • Assess the potential of long‐acting agents to achieve viral suppression in the HTE patient
  • Integrate cultural sensitivity into care for HTE patients of BIPOC communities


JointlyAccreditedProvider Logo In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


PACE designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


ANAC will provide 1.0 contact hour of NCPD for the successful completion of this event
JointlyAccreditedProvider Logo ANAC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


This activity should take approximately 60 minutes to complete.


In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, or NCPD contact hours, participants must receive a score of 75% on the post-test.


Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.


There is no fee for this educational activity.


PACE and ANAC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE and ANCC requirements policy. PACE and ANAC are committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure of Financial Relationships
Sheldon D. Fields, PhD, RN, FNP-BC, AACRN, FAANP, FNAP, FAAN
Associate Dean for Equity and Inclusion
Research Professor
Ross and Carol Nese College of Nursing
The Pennsylvania State University
First Vice President
National Black Nurses Association, Inc.
No relevant financial relationships to disclose
Mamta K. Jain, MD, MPH, FIDSA
Professor Infectious Diseases
UT Southwestern Medical Center
Researcher: Gilead Sciences Inc. and Laurent Pharmaceuticals
Onyema Ogbuagu, MD, FACP, FIDSA
Associate Professor of Medicine &
Director, Antivirals and Vaccines Research Program
Section of Infectious Diseases
Yale School of Medicine
Consultant, Advisor, and Speaker: Gilead Sciences Inc., Janssen Pharmaceuticals, ViiV Healthcare

The PACE, PlatformQ Health Education, LLC and ANAC planners have no relevant financial relationship(s) to disclose with ineligible companies.


This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Accreditation Support:

For additional information about the accreditation of this activity, please visit

Technical Support:

For any technical issues or issues with your CME Certificate, please contact IDCareLive or IDCareLive at 877-394-1306 or at or